Testing a new drug for acute bronchitis
Part of Infections, Lungs & breathing clinical trials.
This trial tests AG2001, a new treatment for acute bronchitis. It aims to see if it reduces cough and sputum better than a placebo, helping you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old.
- You have had a cough and brought up phlegm for less than 2 weeks, and your symptoms started within the last 48 hours.
- Your bronchitis symptoms are moderate to severe (score of 5 or more on a severity scale, with a sputum score of at least 2).
- You do not have a fever higher than 100.7°F (38.5°C) at the start.
- You do not have chronic lung diseases like COPD, asthma, or pneumonia.
- You are not pregnant, breastfeeding, or using certain medications like antibiotics or steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.
This study looks at how well different treatments work for people with lung infections or sudden worsening of chronic lung disease. If you have a respiratory sample available and are about to start an antibiotic, antiviral, antifungal, or steroid, you may be able to join.
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
Hear when a new Acute Bronchitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.